City Drug House – Type 2 Diabetes Pharma Exporter to USA
City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.
Noveltreat 1.7 mg is a once-weekly semaglutide injection approved in India (launched March 2026) for chronic weight management in adults with obesity or overweight, as an adjunct to diet and exercise. It is a GLP-1 receptor agonist that works by increasing feelings of fullness and reducing hunger, available in 0.75 mL pre-filled pens.
Key Therapeutic Applications :
1.Chronic Weight Management: Used for long-term weight management in adults with obesity or overweight who have weight-related comorbidities.
2.Cardiovascular Risk Reduction: Indicated to reduce the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with established cardiovascular disease and obesity or overweight.
3.Metabolic Improvement: Supports weight loss by managing appetite and slowing gastric emptying to aid in portion control.
4.Liver Care: Used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults with moderate to advanced liver scarring.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
